
Helix BioPharma
(OTC) HBPCF
Helix BioPharma Financials at a Glance
Market Cap
$130.61M
Revenue (TTM)
CA$0.00
Net Income (TTM)
-CA$4.25M
EPS (TTM)
-$0.05
P/E Ratio
-37.25
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.71
Volume
1,000
Open
$1.71
Price
$1.71
Volume
1,000
Open
$1.71
Previous Close
$1.71
Daily Range
$1.71 - $1.71
52-Week Range
$0.60 - $1.73
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.71
Volume
1,000
Open
$1.71
Previous Close
$1.71
Daily Range
$1.71 - $1.71
52-Week Range
$0.60 - $1.73
HBPCF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Helix BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
Thomas Mehrling, MD, PhD
Website
www.helixbiopharma.comHeadquarters
Toronto, ON M5H 2Y4, CA
HBPCF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-53%
Return on Capital
-27%
Return on Assets
-23%
Earnings Yield
-2.68%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$130.61M
Shares Outstanding
76.38M
Volume
1.00K
Avg. Volume
22.131
Financials (TTM)
Gross Profit
CA$0.00
Operating Income
-CA$5.00M
EBITDA
-CA$5.00M
Operating Cash Flow
-CA$4.00M
Capital Expenditure
CA$0.00
Free Cash Flow
-CA$4.00M
Cash & ST Invst.
CA$64.64K
Total Debt
CA$333.15K
Helix BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$0.00
N/A
Gross Profit
-CA$1.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$130.61M
N/A
Market Cap/Employee
$18.66M
N/A
Employees
7
N/A
Net Income
-CA$695.09K
+49.4%
EBITDA
-CA$682.07K
+50.2%
Quarterly Fundamentals
Net Cash
-CA$328.52K
-116.5%
Accounts Receivable
CA$25.04K
-89.4%
Inventory
CA$0.00
N/A
Long Term Debt
CA$0.00
N/A
Short Term Debt
CA$359.57K
N/A
Return on Assets
-22.65%
N/A
Return on Invested Capital
-27.11%
N/A
Free Cash Flow
-CA$456.72K
+51.5%
Operating Cash Flow
-CA$456.72K
+51.4%